“…RMW is a consultant to N-of-One Therapeutics, a subsidiary of Qiagen, Inc. Table S1. Marker genes used in analysis are indicated for each cell type hBRAF, crestin, sox10, mitfa, tyrp1a, tyrp1b, dct, pmela (Kaufman et al, 2016) Keratinocytes tp63, krt4 (Eisenhoffer et al, 2017) Fibroblasts fn1a, col1a1a, fstl1b, s100a10b (Gistelinck et al, 2016;Maruyama et al, 2016) Erythrocytes ba1, hbaa1 (Kulkeaw and Sugiyama, 2012) Natural Killers nkl.2, ccl38.6 (Carmona et al, 2017) Neutrophils mpx, mmp9, ncf1 (Carmona et al, 2017) Macrophages ctss2.1, ctss2,2, mhc2dab (Carmona et al, 2017)…”